Moderna has suffered its second PMCPA rebuke in quick succession. Days after ruling Moderna had brought discredit on the ...

CAMBRIDGE, MA and TAIPEI, TAIWAN / ACCESSWIRE / September 30, 2024 / (Nasdaq:MRNA) and Cenra Healthcare, the sales and ...

CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / (NASDAQ:MRNA) today announced that the first participant in the U.S. has ...

CAMBRIDGE, MA and TAIPEI, TAIWAN / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (Nasdaq:MRNA) and Cenra Healthcare, the sales and marketing arm of Cenra Inc., today announced that the companies ...

In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...

Moderna (MRNA) closed at $66.83 in the latest trading session, marking a +1.64% move from the prior day. This change outpaced the S&P 500's 0.42% gain on the day. Meanwhile, the Dow experienced a rise ...

On Friday, Moderna Inc (MRNA) stock saw a modest uptick, ending the day at $65.75 which represents a slight increase of $1.82 or 2.85% from the prior close of $63.93. The stock opened at $64.85 and ...

( MENAFN - GlobeNewsWire - Nasdaq) Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages ...

Stock markets will end the third quarter rewarding investors with record-breaking returns. The S&P 500 added another 5% in Q3 ...

The fall virus season is upon us, and the U.S. Food & Drug Administration just approved one of the newest tools to protect ...

The newest update to the COVID-19 vaccine reached pharmacies as infections in Indiana began to rise. Members of our audience ...

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Moderna, Inc. (NASDAQ: MRNA ) between January 18, 2023 and June 25, 2024, both dates inclusive (the "Class ...